FdaApplication
NDA 206162
Identifiers
- fda_app_no: NDA206162
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2014-12-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYNPARZA | OLAPARIB | 50MG | CAPSULE;ORAL |
1 product